Gut Microbes Could Play a Protective Role Against Chemotherapy Side Effects
Emerging research suggests gut bacteria can reduce chemotherapy side effects, potentially leading to probiotic-based treatments to improve cancer therapy tolerability.
Recent research from the University of California, San Francisco, indicates that gut microbiota may have a significant impact on how patients tolerate chemotherapy treatments. Chemotherapy, essential for cancer treatment, is known to disrupt the natural balance of microbes in the digestive system, often leading to side effects such as nausea, vomiting, and nerve discomfort. However, scientists have discovered that certain bacteria in the gut can help mitigate these adverse effects.
The study focused on colorectal cancer patients undergoing treatment with fluoropyrimidine drugs. Findings revealed that individuals with less diverse gut microbiomes experienced fewer beneficial bacteria capable of breaking down chemotherapy drugs into harmless byproducts. These bacteria essentially act as biological agents that can absorb and chemically modify chemotherapy agents, reducing their toxicity.
Furthermore, researchers observed that measuring specific bacterial populations could predict the severity of side effects. Mice experiments demonstrated that introducing these beneficial microbes improved symptoms of severe chemotherapy toxicity, suggesting potential for probiotic therapies in humans.
A second related study uncovered that some gut bacteria produce vitamin K2, a compound linked to the protection against nerve-related side effects such as numbness and tingling. Patients with higher levels of these bacteria, especially nonpathogenic E. coli strains, reported fewer side effects. Administration of vitamin K2 to mice further supported its role in alleviating chemotherapy-induced discomfort.
This research highlights the critical relationship between the gut microbiome and drug toxicity. Better understanding might lead to new strategies for managing chemotherapy side effects, including targeted probiotics or microbiome modulation. Such approaches could improve treatment outcomes and quality of life for cancer patients.
Source: https://medicalxpress.com/news/2025-05-gut-microbes-patients-chemotherapy-side.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Electrochemical Catheter Hub Aims to Reduce Bloodstream Infections
A new electrochemical catheter hub developed by researchers aims to prevent bloodstream infections by continuously producing disinfectant directly within the device, offering a promising solution to reduce medical device-related infections.
New Study Reveals Vepdegestrant Extends Survival in Patients with Advanced ER+ Breast Cancer Featuring ESR1 Mutations
A new clinical trial reveals that vepdegestrant significantly improves progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations. Learn about the latest advancements in targeted breast cancer therapy.
